Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Feagan · SciRah

Researcher profile · Semantic Scholar

B. Feagan

Share profile

B. Feagan — researcher profile on SciRah

h-index: 142
Works: 1,205
Citations: 82K

Most-cited papers

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
W. Sandborn, S. Vermeire, L. Peyrin-Biroulet, M. Dubinsky +16 more
2023The Lancet282 citations Open access
Semantic Scholar
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial.
B. Feagan, B. Sands, W. Sandborn, M. Germinaro +5 more
2023The Lancet Gastroenterology and Hepatology163 citations
Semantic Scholar
Gut Microbiome Composition is associated with future onset of Crohn's Disease in Healthy First-Degree Relatives.
J. A. Raygoza Garay, W. Turpin, Sun-Ho Lee, Michelle I. Smith +30 more
2023Gastroenterology154 citations Open access
Semantic Scholar
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
L. Peyrin-Biroulet, J. Allegretti, D. Rubin, B. Bressler +159 more
2023Gastroenterology91 citations Open access
Semantic Scholar
Vedolizumab for the Treatment of Chronic Pouchitis.
S. Travis, M. Silverberg, S. Danese, P. Gionchetti +10 more
2023New England Journal of Medicine87 citations Open access
Semantic Scholar
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER).
J. Colombel, R. Ungaro, B. Sands, C. Siegel +9 more
2023Clinical Gastroenterology and Hepatology79 citations Open access
Semantic Scholar
A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice
Dominik Bettenworth, M. Baker, J. Fletcher, V. Jairath +25 more
2024Nature reviews: Gastroenterology & hepatology66 citations Open access
Semantic Scholar
Efficacy and safety of advanced oral small molecules for inflammatory bowel disease: Systematic review and meta-analysis.
V. Solitano, S. Vuyyuru, J. Macdonald, A. Zayadi +8 more
2023Journal of Crohn's & Colitis50 citations Open access
Semantic Scholar
Targeting IL-23 for IBD: Rationale and Progress to Date
S. Vuyyuru, L. Shackelton, J. Hanžel, Christopher Ma +2 more
2023Drugs48 citations
Semantic Scholar
Advanced Combination Treatment With Biologic Agents and Novel Small Molecule Drugs for Inflammatory Bowel Disease.
V. Solitano, Christopher Ma, J. Hanžel, R. Panaccione +2 more
2023Gastroenterology & hepatology47 citations
Semantic Scholar
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn’s Disease and 4 Years in Ulcerative Colitis
Subrata Ghosh, B. Feagan, E. Ott, C. Gasink +9 more
2024Journal of Crohn's & Colitis41 citations Open access
Semantic Scholar
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial
V. Jairath, G. Zou, Zhongyan Wang, S. Adsul +27 more
2024BMJ Open Gastroenterology36 citations Open access
Semantic Scholar
International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statement.
Cathy Lu, R. Rosentreter, C. Parker, J. Rémillard +22 more
2024The Lancet Gastroenterology and Hepatology35 citations
Semantic Scholar
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial.
G. D'Haens, C. Taxonera, A. lópez-sanromán, P. Nos +16 more
2024The Lancet Gastroenterology and Hepatology33 citations Open access
Semantic Scholar
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial.
B. Feagan, B. Sands, Corey A. Siegel, M. Dubinsky +21 more
2025The Lancet Gastroenterology and Hepatology30 citations
Semantic Scholar
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound
Cathy Lu, R. Rosentreter, M. Delisle, M. White +21 more
2024Alimentary Pharmacology and Therapeutics30 citations Open access
Semantic Scholar
Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn’s Disease: Systematic Review and Meta-Analysis
S. Vuyyuru, V. Solitano, M. Hogan, J. Macdonald +9 more
2023Digestive Diseases and Sciences28 citations
Semantic Scholar
Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel disease
Christopher Ma, V. Jairath, B. Feagan, L. Peyrin-Biroulet +3 more
2024Nature reviews: Gastroenterology & hepatology24 citations
Semantic Scholar
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease.
F. Rieder, Christopher Ma, J. Hanžel, J. Fletcher +16 more
2024Radiology20 citations Open access
Semantic Scholar
Reliability of intestinal ultrasound for evaluating Crohn's disease activity using point-of-care and central reading.
T. Goodsall, Yoon-Kyo An, Jane M. Andrews, J. Begun +19 more
2024Clinical Gastroenterology and Hepatology20 citations
Semantic Scholar
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease.
F. Rieder, M. Baker, D. Bruining, Jeff L. Fidler +25 more
2024Radiology19 citations Open access
Semantic Scholar
Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION Trial
S. Schreiber, B. Feagan, L. Peyrin-Biroulet, S. Vermeire +6 more
2023Journal of Crohn's & Colitis17 citations Open access
Semantic Scholar
Mucosal Healing With Vedolizumab in Patients with Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled Trial.
V. Jairath, B. Feagan, M. Silverberg, S. Danese +10 more
2024Clinical Gastroenterology and Hepatology16 citations Open access
Semantic Scholar
Standardizing Randomized Controlled Trials in Celiac Disease: An International Multidisciplinary Appropriateness Study
B. Lebwohl, Christopher Ma, Stephen M. Lagana, R. Pai +21 more
2023Gastroenterology15 citations Open access
Semantic Scholar
Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn’s Disease
Subrata Ghosh, B. Feagan, R. Parra, Susana Lopes +10 more
2024Journal of Crohn's & Colitis13 citations Open access
Semantic Scholar
Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial
I. Dotan, B. Feagan, Virginia Taliadouros, A. Oortwijn +6 more
2023Journal of Crohn's & Colitis12 citations Open access
Semantic Scholar
Incidence of Total Knee Arthroplasty After Arthroscopic Surgery for Knee Osteoarthritis
T. Birmingham, C. Primeau, Salimah Z. Shariff, Jennifer Reid +8 more
2024JAMA Network Open11 citations Open access
Semantic Scholar
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn’s Disease
Sarah Harris, B. Feagan, S. Hanauer, S. Vermeire +7 more
2024Digestive Diseases and Sciences11 citations Open access
Semantic Scholar
Placebo rates in Crohn’s disease randomized clinical trials: An individual patient data meta-analysis
V. Solitano, M. Hogan, Siddharth Singh, S. Danese +9 more
2024Gastroenterology11 citations Open access
Semantic Scholar
Standardizing Scoring Conventions for Crohn's Disease Endoscopy: An International RAND/UCLA Appropriateness Study.
R. Khanna, Christopher Ma, M. Hogan, G. Zou +20 more
2023Clinical Gastroenterology and Hepatology11 citations Open access
Semantic Scholar
Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review.
K. Falloon, Zahra Dossaji, Pooja J. Mude, S. Abushamma +29 more
2024Inflammatory Bowel Diseases10 citations
Semantic Scholar
Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.
Eileen Crowley, Christopher Ma, L. Guizzetti, G. Zou +18 more
2023Inflammatory Bowel Diseases10 citations Open access
Semantic Scholar
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease
J. Hanžel, V. Solitano, S. Vuyyuru, R. Panaccione +46 more
2025Gastroenterology9 citations Open access
Semantic Scholar
759 THE EFFICACY AND SAFETY OF GUSELKUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR MAINTENANCE STUDY
D. Rubin, J. Allegretti, J. Panes, N. Shipitofsky +12 more
2024Gastroenterology9 citations
Semantic Scholar
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug–Drug Interactions
Jie Shao, Marion L. Vetter, An Vermeulen, B. Feagan +3 more
2024Clinical pharmacology and therapy9 citations
Semantic Scholar
Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitis
M. Dubinsky, V. Jairath, B. Feagan, A. Naegeli +8 more
2023BMJ Open Gastroenterology9 citations Open access
Semantic Scholar
Exposure–efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn’s disease and ulcerative colitis
G. D'Haens, M. Rosario, Daniel Polhamus, N. Dirks +6 more
2024Expert Review of Clinical Pharmacology8 citations Open access
Semantic Scholar
Identification of immune cell markers associated with ulcerative colitis histological disease activity in colonic biopsies
Pavine L. C. Lefèvre, Zhongyan Wang, W. Teft, G. Zou +6 more
2024Journal of Clinical Pathology8 citations
Semantic Scholar
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients With Moderately to Severely Active Crohn's Disease.
M. Allez, B. Sands, B. Feagan, G. D'Haens +11 more
2023Journal of Crohn's & Colitis8 citations Open access
Semantic Scholar
Serum Extracellular Matrix Molecules and Their Fragments as Biomarkers of Inflammation and Fibrosis in Inflammatory Bowel Diseases - A Systematic Review.
Anja Poulsen, P. D. Ovesen, Cathy Lu, Dominik Bettenworth +4 more
2024Journal of Crohn's & Colitis7 citations
Semantic Scholar
Development and validation of a novel Endoscopic ulcer Activity Score for Evaluation of Crohn's Disease (EASE-CD) using data from two randomised controlled trials.
Christopher Ma, R. Khanna, B. Maguire, G. Zou +16 more
2025The Lancet Gastroenterology and Hepatology6 citations Open access
Semantic Scholar
Responsiveness of Different Disease Activity Indices in Moderate-to-Severe Ulcerative Colitis
V. Solitano, R. Panaccione, B. Sands, Zhongyan Wang +9 more
2024i Medicina6 citations Open access
Semantic Scholar
Definitions, Diagnosis and Management of Postoperative Recurrence in Crohn's Disease Patients with Permanent Ileostomy - A Systematic Review and Meta-Analysis.
S. Abushamma, Tesfaye Yadete, Neil Nero, K. Falloon +32 more
2025Journal of Crohn's & Colitis5 citations Open access
Semantic Scholar
Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn’s Disease
B. Feagan, J. Colombel, R. Panaccione, S. Schreiber +10 more
2024Gastro Hep Advances5 citations Open access
Semantic Scholar
Performance of bowel preparation quality scales in patients with Crohn's disease
V. Solitano, C. Siegel, J. Korzenik, J. Maratt +12 more
2024Alimentary Pharmacology and Therapeutics5 citations Open access
Semantic Scholar
Discordance between MR enterography and endoscopic detection of Crohn’s disease ileal strictures: evidence to inform recommendations
M. Yalon, P. Mohammadinejad, Akitoshi Inoue, Hiroaki Takahashi +13 more
2024Abdominal Radiology5 citations
Semantic Scholar
P268 Development and validation of a novel composite index for the assessment of endoscopic and histologic disease activity in pouchitis: The Atlantic pouchitis index
R. Sedano, Christopher Ma, M. Hogan, M. Silverberg +17 more
2023Journal of Crohn's & Colitis5 citations Open access
Semantic Scholar
Management of Small Bowel Crohn's Disease Strictures: To cut, to stretch or to treat inflammation?
Cathy Lu, B. Feagan, J. Fletcher, M. Baker +2 more
2024Gastroenterology4 citations
Semantic Scholar
Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies
S. Vermeire, B. Feagan, L. Peyrin-Biroulet, A. Oortwijn +3 more
2023Journal of Crohn's & Colitis4 citations Open access
Semantic Scholar
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis.
S. Vuyyuru, Tran M. Nguyen, M. Hogan, T. Raine +7 more
2023Inflammatory Bowel Diseases4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Jairath×24
Invite
V. Jairath — researcher profile on SciRah
R. Panaccione×11
Invite
R. Panaccione — researcher profile on SciRah
F. Rieder×10
Invite
F. Rieder — researcher profile on SciRah
W. Sandborn×9
Invite
W. Sandborn — researcher profile on SciRah

×9

Invite

G. Zou — researcher profile on SciRah

J. Rémillard×9

Invite

J. Rémillard — researcher profile on SciRah

Invite

B. Sands — researcher profile on SciRah

Invite

V. Solitano — researcher profile on SciRah

Christopher Ma×8

Invite

Christopher Ma — researcher profile on SciRah

Invite

M. Hogan — researcher profile on SciRah

L. Peyrin-Biroulet×7

Invite

L. Peyrin-Biroulet — researcher profile on SciRah

Invite

M. Baker — researcher profile on SciRah